Vivacity-MG: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Nipocalimab Administered to Adults with Generalized Myasthenia Gravis
Publication
, Conference
Guptill, J; Antozzi, C; Bril, V; Gamez, J; Meuth, SG; Blanco, JLM; Nowak, RJ; Quan, D; Sevilla, T; Szczudlik, A; Hegarty, B; Jouvin, M-H ...
Published in: NEUROLOGY
2021
Duke Scholars
Published In
NEUROLOGY
EISSN
1526-632X
ISSN
0028-3878
Publication Date
2021
Volume
96
Issue
15
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences
- 1702 Cognitive Sciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Guptill, J., Antozzi, C., Bril, V., Gamez, J., Meuth, S. G., Blanco, J. L. M., … Arroyo, S. (2021). Vivacity-MG: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Nipocalimab Administered to Adults with Generalized Myasthenia Gravis. In NEUROLOGY (Vol. 96).
Guptill, Jeffrey, Carlo Antozzi, Vera Bril, Josep Gamez, Sven G. Meuth, Jose Luis Munoz Blanco, Richard J. Nowak, et al. “Vivacity-MG: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Nipocalimab Administered to Adults with Generalized Myasthenia Gravis.” In NEUROLOGY, Vol. 96, 2021.
Guptill J, Antozzi C, Bril V, Gamez J, Meuth SG, Blanco JLM, et al. Vivacity-MG: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Nipocalimab Administered to Adults with Generalized Myasthenia Gravis. In: NEUROLOGY. 2021.
Guptill, Jeffrey, et al. “Vivacity-MG: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Nipocalimab Administered to Adults with Generalized Myasthenia Gravis.” NEUROLOGY, vol. 96, no. 15, 2021.
Guptill J, Antozzi C, Bril V, Gamez J, Meuth SG, Blanco JLM, Nowak RJ, Quan D, Sevilla T, Szczudlik A, Hegarty B, Jouvin M-H, Jin J, Arroyo S. Vivacity-MG: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Nipocalimab Administered to Adults with Generalized Myasthenia Gravis. NEUROLOGY. 2021.
Published In
NEUROLOGY
EISSN
1526-632X
ISSN
0028-3878
Publication Date
2021
Volume
96
Issue
15
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences
- 1702 Cognitive Sciences
- 1109 Neurosciences
- 1103 Clinical Sciences